prazosin has been researched along with Arrhythmia in 41 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prazosin, an orally active alpha-1 selective adrenergic antagonist, has been of value in treating patients with hypertension and congestive heart failure." | 8.76 | Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications. ( Colucci, WS, 1982) |
| "Cocaine-induced increases in catecholamines and the resulting enhanced activation of myocardial adrenergic receptors could contribute significantly to the formation of ventricular fibrillation (VF)." | 7.69 | The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate. ( Billman, GE, 1994) |
| "The effects of iloprost, prazosin and propranolol were tested on ouabain-induced arrhythmia in guinea-pigs." | 7.68 | Alpha- but not beta-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs. ( Balewska, I; Mest, HJ, 1991) |
| "The authors determined whether increasing alpha 1-adrenergic blockade resulted in progressively less arrhythmic activity in the canine halothane-epinephrine arrhythmia model." | 7.67 | Alpha 1-adrenergic blockade raises epinephrine-arrhythmia threshold in halothane-anesthetized dogs in a dose-dependent fashion. ( Gaba, DM; Hayward, E; Maze, M, 1985) |
| "Ischemia-induced arrhythmias were studied during a 30 min period of occlusion of the left anterior descending (LAD) coronary artery, and 100% of control animals (n = 24) exhibited ventricular tachycardia and 63% ventricular fibrillation." | 5.27 | Ischemia- and reperfusion-induced arrhythmias in conscious rats--studies with prazosin and atenolol. ( Braimbridge, MV; Hearse, DJ; Kinoshita, K; Manning, AS, 1988) |
| "Prazosin, an orally active alpha-1 selective adrenergic antagonist, has been of value in treating patients with hypertension and congestive heart failure." | 4.76 | Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications. ( Colucci, WS, 1982) |
| "Cocaine-induced increases in catecholamines and the resulting enhanced activation of myocardial adrenergic receptors could contribute significantly to the formation of ventricular fibrillation (VF)." | 3.69 | The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate. ( Billman, GE, 1994) |
| "The effects of iloprost, prazosin and propranolol were tested on ouabain-induced arrhythmia in guinea-pigs." | 3.68 | Alpha- but not beta-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs. ( Balewska, I; Mest, HJ, 1991) |
| " In those hearts exhibiting arrhythmias, [3H]-prazosin binding to alpha 1-adrenoceptors of ventricular membrane fractions was measured and compared with normally perfused time-matched controls." | 3.68 | Arrhythmias and alpha 1-adrenoceptor binding characteristics of the guinea-pig perfused heart during ischaemia and reperfusion. ( Broadley, KJ; Chess-Williams, RG; Sheridan, DJ, 1990) |
| "The possible antiarrhythmic action of prazosin was studied on two experimental models: a focus of ectopic automaticity in the rat isolated right ventricle and arrhythmias induced by i." | 3.67 | In vitro and in vivo antiarrhythmic effects of prazosin in the rat. ( Duran, JA; Miñano, FJ; Serrano, JS, 1984) |
| "The antiarrhythmic and antifibrillatory actions of the alpha 1-adrenoceptor antagonist prazosin were evaluated in conscious dogs 4-7 days after anterior myocardial infarction." | 3.67 | Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin. ( Lucchesi, BR; Lynch, JJ; Montgomery, DG; Wilber, DJ, 1987) |
| "The authors determined whether increasing alpha 1-adrenergic blockade resulted in progressively less arrhythmic activity in the canine halothane-epinephrine arrhythmia model." | 3.67 | Alpha 1-adrenergic blockade raises epinephrine-arrhythmia threshold in halothane-anesthetized dogs in a dose-dependent fashion. ( Gaba, DM; Hayward, E; Maze, M, 1985) |
| "35%) anesthesia, the arrhythmogenic dose of epinephrine (ADE) was repeatedly determined before and after prazosin (alpha 1 antagonist; 0." | 3.67 | Alterations in the arrhythmogenic dose of epinephrine after adrenergic receptor blockade with prazosin, metoprolol, or yohimbine in halothane-xylazine-anesthetized dogs. ( Benson, GJ; Thurmon, JC; Tranquilli, WJ, 1986) |
| "Ventricular arrhythmia was a significant independent predictor in V-HeFT II but not in V-HeFT I." | 2.67 | Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. ( Cohn, JN; Fletcher, R; Johnson, GR; Loeb, H; Rector, T; Shabetai, R; Smith, R; Tristani, F, 1993) |
| "Incidences and severity of ventricular arrhythmia during ischemia and early reperfusion significantly decreased in noradrenaline preconditioned group compared with saline-control group." | 1.37 | Noradrenaline protects in vivo rat heart against infarction and ventricular arrhythmias via nitric oxide and reactive oxygen species. ( Alizadeh, AM; Faghihi, M; Imani, A; Niaraki, SS; Sadr, SS, 2011) |
| "Atenolol and prazosin treatment lowered heart rates and blood pressures respectively, but neither agent given alone affected the incidence of phase 2 ventricular tachycardia or fibrillation." | 1.35 | Complex adrenergic and inflammatory mechanisms contribute to phase 2 ventricular arrhythmias in anaesthetized rats. ( Andrag, E; Clements-Jewery, H; Curtis, MJ; Hearse, DJ, 2009) |
| "The severity of arrhythmias (arrhythmia score, AS) was also markedly attenuated by both interventions (IPC: AS 1." | 1.31 | Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels. ( Pancza, D; Ravingerová, T; Styk, J; Ziegelhoffer, A, 2002) |
| "The incidence of arrhythmia was blocked by S-2150, and this effect offered protection against cardiac death." | 1.29 | Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 1. Antinecrotic and antiarrhythmic effects in reperfused rat hearts. ( Funakawa, S; Iwaki, K; Masui, M; Matsunaga, K; Mihara, S; Takahara, Y; Uno, O, 1996) |
| "4." | 1.28 | Enhanced alpha-adrenoceptor responsiveness and receptor number during global ischaemia in the Langendorff perfused rat heart. ( Butterfield, MC; Chess-Williams, R, 1990) |
| "Atropine treatment lowered the ADE to 1." | 1.28 | Comparison of arrhythmogenic doses of epinephrine in heartworm-infected and noninfected dogs. ( Holmes, E; O'Malley, NA; Venugopalan, CS, 1989) |
| "In phentolamine-treated dogs, arterial pressure and heart rate were kept constant to prevent exacerbation of ischemia." | 1.27 | Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog. ( Bolli, R; Fisher, DJ; Miller, RR; Taylor, AA; Young, JB, 1984) |
| "Prazosin and atenolol were able to reduce significantly the incidence of ventricular fibrillation and LDH release." | 1.27 | Reoxygenation dysrhythmias in the isolated guinea-pig heart: sensitivity to prazosin, atenolol and practolol. ( Antonini, G; Franconi, F; Giotti, A; Ledda, F; Mantelli, L; Stendardi, I, 1983) |
| "Ischemia-induced arrhythmias were studied during a 30 min period of occlusion of the left anterior descending (LAD) coronary artery, and 100% of control animals (n = 24) exhibited ventricular tachycardia and 63% ventricular fibrillation." | 1.27 | Ischemia- and reperfusion-induced arrhythmias in conscious rats--studies with prazosin and atenolol. ( Braimbridge, MV; Hearse, DJ; Kinoshita, K; Manning, AS, 1988) |
| "Protection from arrhythmias seems to be related to the combined presence of a noncompetitive adrenergic blockade associated with salutary effects on coronary circulation." | 1.27 | The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. ( Schwartz, PJ; Vanoli, E; Zaza, A; Zuanetti, G, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (58.54) | 18.7374 |
| 1990's | 13 (31.71) | 18.2507 |
| 2000's | 2 (4.88) | 29.6817 |
| 2010's | 2 (4.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clements-Jewery, H | 1 |
| Andrag, E | 1 |
| Hearse, DJ | 3 |
| Curtis, MJ | 1 |
| Imani, A | 1 |
| Faghihi, M | 1 |
| Sadr, SS | 1 |
| Niaraki, SS | 1 |
| Alizadeh, AM | 1 |
| Okamoto, Y | 1 |
| Takano, M | 1 |
| Ohba, T | 1 |
| Ono, K | 1 |
| Ravingerová, T | 1 |
| Pancza, D | 1 |
| Ziegelhoffer, A | 1 |
| Styk, J | 1 |
| Colucci, WS | 1 |
| Heinecker, R | 1 |
| Sharma, AD | 1 |
| Saffitz, JE | 1 |
| Lee, BI | 1 |
| Sobel, BE | 1 |
| Corr, PB | 1 |
| Maze, M | 2 |
| Smith, CM | 1 |
| Opie, LH | 3 |
| Bolli, R | 1 |
| Fisher, DJ | 1 |
| Taylor, AA | 1 |
| Young, JB | 1 |
| Miller, RR | 1 |
| Antonini, G | 1 |
| Franconi, F | 1 |
| Giotti, A | 1 |
| Ledda, F | 1 |
| Mantelli, L | 1 |
| Stendardi, I | 1 |
| Kather, H | 1 |
| Miñano, FJ | 1 |
| Serrano, JS | 1 |
| Duran, JA | 1 |
| Ram, CV | 1 |
| Billman, GE | 1 |
| Vanoli, E | 3 |
| Hull, SS | 1 |
| Foreman, RD | 1 |
| Ferrari, A | 1 |
| Schwartz, PJ | 3 |
| Liusov, VA | 1 |
| Volov, NA | 1 |
| Dibirova, GO | 1 |
| Uteshev, DB | 1 |
| Saeki, K | 1 |
| Ogawa, S | 1 |
| Sadanaga, T | 1 |
| Yoh, S | 1 |
| Furuno, I | 1 |
| Nakamura, Y | 1 |
| Cohn, JN | 1 |
| Johnson, GR | 1 |
| Shabetai, R | 1 |
| Loeb, H | 1 |
| Tristani, F | 1 |
| Rector, T | 1 |
| Smith, R | 1 |
| Fletcher, R | 1 |
| Roegel, JC | 1 |
| De Jong, W | 1 |
| Monassier, L | 1 |
| Feldman, J | 1 |
| Bousquet, P | 1 |
| Masui, M | 1 |
| Funakawa, S | 1 |
| Uno, O | 1 |
| Mihara, S | 1 |
| Takahara, Y | 1 |
| Matsunaga, K | 1 |
| Iwaki, K | 1 |
| Parikh, V | 1 |
| Singh, M | 1 |
| Mest, HJ | 1 |
| Balewska, I | 1 |
| Chess-Williams, RG | 1 |
| Sheridan, DJ | 2 |
| Broadley, KJ | 1 |
| Butterfield, MC | 1 |
| Chess-Williams, R | 1 |
| Kawai, T | 1 |
| Okumura, K | 1 |
| Hashimoto, H | 1 |
| Ito, T | 1 |
| Satake, T | 1 |
| Vaughan Williams, EM | 1 |
| Harron, DW | 1 |
| Wilber, DJ | 1 |
| Lynch, JJ | 1 |
| Montgomery, DG | 1 |
| Lucchesi, BR | 1 |
| Venugopalan, CS | 1 |
| Holmes, E | 1 |
| O'Malley, NA | 1 |
| Manning, AS | 2 |
| Crome, R | 1 |
| Klein, N | 1 |
| Maguire, ME | 1 |
| Bralet, J | 1 |
| Didier, J | 1 |
| Moreau, D | 1 |
| Rochette, L | 1 |
| Hayward, E | 1 |
| Gaba, DM | 1 |
| Davey, MJ | 1 |
| Thandroyen, FT | 1 |
| Flint, NS | 1 |
| Worthington, MG | 1 |
| Kinoshita, K | 1 |
| Braimbridge, MV | 1 |
| Tranquilli, WJ | 2 |
| Thurmon, JC | 2 |
| Benson, GJ | 2 |
| Zaza, A | 1 |
| Zuanetti, G | 1 |
3 reviews available for prazosin and Arrhythmia
| Article | Year |
|---|---|
Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Child; Drug Tolerance; Heart Failure; H | 1982 |
Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Hemodynamics; Humans; H | 1993 |
Alpha adrenoceptors--an overview.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Catecholamines; Child, Preschool; Coron | 1986 |
1 trial available for prazosin and Arrhythmia
| Article | Year |
|---|---|
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
Topics: Arrhythmias, Cardiac; Cardiomegaly; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Hyd | 1993 |
37 other studies available for prazosin and Arrhythmia
| Article | Year |
|---|---|
Complex adrenergic and inflammatory mechanisms contribute to phase 2 ventricular arrhythmias in anaesthetized rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atenolol; | 2009 |
Noradrenaline protects in vivo rat heart against infarction and ventricular arrhythmias via nitric oxide and reactive oxygen species.
Topics: Adrenergic alpha-Agonists; Animals; Arrhythmias, Cardiac; Cyclic N-Oxides; Ischemic Preconditioning, | 2011 |
Arrhythmogenic coupling between the Na+ -Ca2+ exchanger and inositol 1,4,5-triphosphate receptor in rat pulmonary vein cardiomyocytes.
Topics: Action Potentials; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Arrh | 2012 |
Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.
Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Ant | 2002 |
[Frequent errors in the therapy of heart disease].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biologic | 1982 |
Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; C | 1983 |
Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Arrhythmias, Cardiac; Dogs; Epinephrine; Halothan | 1983 |
Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channe | 1984 |
Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Carbon Dioxide; Coronar | 1984 |
Reoxygenation dysrhythmias in the isolated guinea-pig heart: sensitivity to prazosin, atenolol and practolol.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Electrocardiography; Guinea Pigs; Heart; In Vitro Technique | 1983 |
[Hypertensive therapy with prazosin. Concomitant cardiovascular, metabolic and respiratory diseases. Proven facts and potential aspects].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiovascular Diseases; Diabetes Complications; Humans; Hy | 1984 |
In vitro and in vivo antiarrhythmic effects of prazosin in the rat.
Topics: Animals; Arrhythmias, Cardiac; Calcium Chloride; Female; Heart Rate; In Vitro Techniques; Male; Praz | 1984 |
The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; | 1994 |
Alpha 1-adrenergic blockade and sudden cardiac death.
Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac | 1994 |
[The prognosis of drug therapy efficacy in ventricular rhythm disorders by the level of intracellular Ca2+ in the lymphocytes of patients with ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium; Drug Evaluation; Drug Therapy, Combinat | 1993 |
Sympathetic denervation of the epicardial border zone in the genesis of dispersion of refractoriness and arrhythmogenesis in a 7-day-old canine myocardial infarction model.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Models, Biological; Myocardial Infarction | 1993 |
Comparative effects of idazoxan, prazosin, and yohimbine on coronary ligation-induced arrhythmias in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Coronary Vessels; Hemodynamics; Idazoxa | 1996 |
Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 1. Antinecrotic and antiarrhythmic effects in reperfused rat hearts.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel | 1996 |
Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Cell Degranu | 1999 |
Alpha- but not beta-receptor blocking agents inhibit the antiarrhythmic effect of iloprost on ouabain-induced arrhythmia in guinea-pigs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Drug Inter | 1991 |
Arrhythmias and alpha 1-adrenoceptor binding characteristics of the guinea-pig perfused heart during ischaemia and reperfusion.
Topics: Adrenergic Agonists; Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Guinea Pigs; Heart | 1990 |
Enhanced alpha-adrenoceptor responsiveness and receptor number during global ischaemia in the Langendorff perfused rat heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Binding Sites; Coronary Disease; Heart Rate; | 1990 |
Alteration of 1,2-diacylglycerol content in ischemic and reperfused heart.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Diglycerides; Dogs; Kinetics; Male; Myocardial Repe | 1990 |
Cardiac electrophysiological effects of selective adrenoceptor stimulation and their possible roles in arrhythmias.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Heart; Heart Rat | 1985 |
Experimental evidence for the antiarrhythmic action of indoramin.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cats; Coronary Vessels; Electrocardiography; Guinea P | 1986 |
Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Dogs; Electrophysiology; Hemodynamics; | 1987 |
Comparison of arrhythmogenic doses of epinephrine in heartworm-infected and noninfected dogs.
Topics: Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Atropine; Blood Pressure; Carbon Dioxide; Dir | 1989 |
Dissociation between reperfusion induced arrhythmias and increases in ventricular alpha 1 receptor density in the anaesthetised rat.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Heart Ventricles; Male; Myocardial Reperfusion Inju | 1989 |
Effect of alpha-adrenoceptor antagonists (phentolamine, nicergoline and prazosin) on reperfusion arrhythmias and noradrenaline release in perfused rat heart.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Heart; In Vitro Techniques; Male; Myoca | 1985 |
Alpha 1-adrenergic blockade raises epinephrine-arrhythmia threshold in halothane-anesthetized dogs in a dose-dependent fashion.
Topics: Adrenergic alpha-Antagonists; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Dose-Resp | 1985 |
Alpha adrenoceptors and arrhythmias.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Catecholamines; Coronary Disease; Guine | 1986 |
Arrhythmogenic action of alpha 1-adrenoceptor stimulation in normoxic rat ventricular myocardium: influence of nisoldipine, reduced extracellular Ca2+ and ryanodine.
Topics: Adrenergic alpha-Agonists; Alkaloids; Animals; Arrhythmias, Cardiac; Azepines; Calcium; Calcium Chan | 1987 |
Ischemia- and reperfusion-induced arrhythmias in conscious rats--studies with prazosin and atenolol.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Male; Myocard | 1988 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem | 1986 |
Halothane-catecholamine arrhythmias in swine (Sus scrofa).
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Blood Pressure; Epinephrine; Female; Halothane; Heart Rat | 1986 |
Alterations in the arrhythmogenic dose of epinephrine after adrenergic receptor blockade with prazosin, metoprolol, or yohimbine in halothane-xylazine-anesthetized dogs.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Epinephrine; Fema | 1986 |
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Disease M | 1985 |